Los Angeles Capital Management LLC lowered its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 5.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 192,989 shares of the financial services provider’s stock after selling 11,249 shares during the quarter. Los Angeles Capital Management LLC’s holdings in CME Group were worth $44,818,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of the business. Geode Capital Management LLC boosted its stake in CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after buying an additional 142,692 shares in the last quarter. Janus Henderson Group PLC raised its holdings in CME Group by 17.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock worth $554,707,000 after purchasing an additional 380,071 shares during the last quarter. Franklin Resources Inc. raised its holdings in CME Group by 70.4% during the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. Two Sigma Advisers LP grew its position in shares of CME Group by 11.9% during the 3rd quarter. Two Sigma Advisers LP now owns 2,230,100 shares of the financial services provider’s stock worth $492,072,000 after buying an additional 237,800 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of CME Group by 1.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,981,961 shares of the financial services provider’s stock worth $437,320,000 after buying an additional 26,642 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Stock Performance
NASDAQ:CME opened at $247.75 on Tuesday. The stock’s 50-day simple moving average is $237.34 and its 200 day simple moving average is $227.99. The firm has a market capitalization of $89.28 billion, a PE ratio of 25.62, a price-to-earnings-growth ratio of 6.76 and a beta of 0.57. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $253.53.
CME Group declared that its board has authorized a share repurchase plan on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.
CME Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 2.02%. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 51.71%.
Insiders Place Their Bets
In other CME Group news, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
CME has been the subject of several research analyst reports. Barclays boosted their price objective on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Morgan Stanley upped their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 19th. Keefe, Bruyette & Woods upped their price target on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Piper Sandler upped their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Finally, Oppenheimer upped their price target on CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $236.13.
Read Our Latest Analysis on CME Group
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- How Investors Can Find the Best Cheap Dividend Stocks
- Institutions Signal Opportunty to Buy High-Yield Kraft-Heinz
- How to Buy Cheap Stocks Step by Step
- 3 Explosive Tech Stocks Breaking Out Right Now
- Growth Stocks: What They Are, Examples and How to Invest
- BigBear.ai: Is It Opportunity Knocking or a Trap Door?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.